高级检索
当前位置: 首页 > 详情页

Guideline for the evaluation of prescription appropriateness

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Beijing Jishuitan Hosp, Dept Pharm, Beijing, Peoples R China [2]Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou, Peoples R China [3]Lanzhou Univ, Chinese GRADE Ctr, Lanzhou, Peoples R China [4]Peking Union Med Coll Hosp, Dept Pharm, Beijing, Peoples R China [5]Fudan Univ, Huashan Hosp, Dept Pharm, Shanghai, Peoples R China [6]Suzhou Univ, Affiliated Hosp 1, Dept Pharm, Suzhou, Peoples R China [7]Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Pharm, Hangzhou, Peoples R China [8]AnHui Prov Hosp, Dept Pharm, Hefei, Peoples R China [9]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pharm, Wuhan, Peoples R China [10]Changhai Hosp, Dept Pharm, Shanghai, Peoples R China [11]Sichuan Univ, West China Res Ctr Clin Pharm, Dept Pharm, Chengdu, Peoples R China [12]China Japan Friendship Hosp, Dept Pharm, Beijing, Peoples R China [13]Beijing Hosp Author, Dept Pharmaceut Affairs, Beijing, Peoples R China
出处:
ISSN:

关键词: Prescription comment inappropriate prescription prescription error guideline

摘要:
Evaluation of prescriptions is a necessary process of evaluating the appropriateness of clinical drug usage, discovering existing problems, and formulating solutions. There are challenges for professionals within hospital medical departments and for clinicians and pharmacists who have clinical questions relating to inappropriate or abnormal prescriptions as identified by the electronic evaluation system of prescription. Medications are usually used correctly according to the drug instructions or guidelines. At present, there are no relevant domestic or international guidelines, or principles or standards for identifying inappropriate or abnormal prescriptions. To develop the guideline for evaluation of prescriptions appropriateness in clinical practice, the Pharmaceutical Affairs Commission of the Chinese Hospital Association formed the guideline working group consisting of multidisciplinary experts. The guideline working group summarized clinical questions in the evaluation of prescriptions, searched for supporting evidence, and reached a consensus for recommendations. The guideline contains 6 recommendations for evaluating prescription appropriateness, and the general principle of these recommendations is that clinicians should provide drug instructions, guidelines, or moderate evidence supporting the prescription, and the evaluators will then judge the prescription to be either appropriate or irrational. The recommendations resolve common clinical questions, using supporting examples, explanations and a flow chart. The evaluation of prescription appropriateness could be made more systematic and transparent based on this guideline's conclusions.

语种:
WOS:
中科院(CAS)分区:
出版当年[2020]版
大类 | 3 区 医学
小类 | 3 区 医学:研究与实验 3 区 肿瘤学
最新[2025]版:
JCR分区:
出版当年[2019]版:
Q2 ONCOLOGY Q2 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2019版] 出版当年五年平均[2015-2019] 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Beijing Jishuitan Hosp, Dept Pharm, Beijing, Peoples R China
通讯作者:
通讯机构: [1]Beijing Jishuitan Hosp, Dept Pharm, Beijing, Peoples R China [2]Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou, Peoples R China [3]Lanzhou Univ, Chinese GRADE Ctr, Lanzhou, Peoples R China [*1]199 Donggang Rd West, Lanzhou, Peoples R China [*2]31 Xinjiekou E Rd, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)